Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugate
antibody-drug conjugate
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
AbbVie
M&A
antibody-drug conjugate
Immunogen
Elahere
ovarian cancer
Regeneron stays out of ADC deal fray as in-house scientists tinker
Fierce Biotech
Wed, 11/15/23 - 11:08 am
Regeneron
antibody-drug conjugate
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
Motley Fool
Sun, 11/12/23 - 09:30 pm
Merck
Bristol Myers Squibb
antibody-drug conjugate
Bristol Myers pays $100M for a different kind of ADC
BioPharma Dive
Mon, 11/6/23 - 09:54 am
Bristol Myers Squibb
antibody-drug conjugate
bone cancer
blood cancer
Orum Therapeutics
Daiichi-Sankyo ups revenue forecast thanks to massive Merck deal
Fierce Biotech
Tue, 10/31/23 - 09:30 pm
Daiichi Sankyo
Merck
antibody-drug conjugate
‘We knew it was there’: AbbVie CEO says company favored internal work over potential Daiichi deal
Fierce Biotech
Sun, 10/29/23 - 08:56 pm
AbbVie
Daiichi Sankyo
Merck
antibody-drug conjugate
ESMO: Ambrx's 'reset' arrives at the last line of prostate cancer, offering the kind of safety rarely seen
Fierce Biotech
Mon, 10/23/23 - 10:33 am
ESMO
Ambrx
prostate cancer
ARX517
antibody-drug conjugate
In 2nd big ADC deal of the day, GSK inks $2B-plus pact for Hansoh gynecology cancer asset
Fierce Biotech
Sun, 10/22/23 - 06:13 pm
GSK
antibody-drug conjugate
Hansoh Pharmaceutical
ESMO: Seagen and Genmab's Tivdak keeps cervical cancer patients alive longer
Fierce Pharma
Sun, 10/22/23 - 06:11 pm
ESMO
Pfizer
Seagen
cervical cancer
antibody-drug conjugate
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Fierce Biotech
Fri, 10/20/23 - 09:55 am
Merck
Daiichi Sankyo
AstraZeneca
antibody-drug conjugate
Lilly links up European ADC network, snagging Elahere rival in latest biotech buy
Fierce Biotech
Thu, 10/19/23 - 10:10 am
Eli Lilly
M&A
antibody-drug conjugate
Elahere
Mablink
BioNTech Inks Potential $1B Deal with MediLink for Cancer-Focused ADCs
BioSpace
Fri, 10/13/23 - 11:56 am
BioNTech
MediLink
cancer
antibody-drug conjugate
BioNTech takes another leaf out of Daiichi playbook, paying $70M for HER3-directed ADC
Fierce Biotech
Thu, 10/12/23 - 10:07 am
BioNTech
Daiichi Sankyo
antibody-drug conjugate
breast cancer
AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead
BioSpace
Fri, 09/22/23 - 11:51 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
AstraZeneca, Daiichi Sankyo show off ADC portfolio with safety top of mind
Fierce Biotech
Tue, 09/12/23 - 12:00 pm
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
non-small cell lung cancer
Dato-DXd
Nurix and Seagen Collaborate on Breakthrough Cancer Therapeutics
Globe Newswire
Thu, 09/7/23 - 10:57 am
Nurix Therapeutics
Seagen
protein degradation
cancer
antibody-drug conjugate
AbbVie Removes Two Early-Stage Cancer Assets from Pipeline
BioSpace
Thu, 08/24/23 - 11:44 am
AbbVie
antibody-drug conjugate
cancer
Former Big Pharma darling Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs
Fierce Biotech
Fri, 08/11/23 - 10:07 am
Atreca
antibody-drug conjugate
layoffs
Sutro strengthens its immuno-oncology pipeline with two new ADCs
Clinical Trials Arena
Fri, 08/11/23 - 10:03 am
Sutro BioPharma
immuno-oncology
antibody-drug conjugate
Seagen, Merck put $1.6B ADC collab on the back burner citing 'emerging treatment landscape'
Fierce Biotech
Thu, 08/3/23 - 06:27 pm
Seagen
Merck
antibody-drug conjugate
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »